CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

François Ghiringhelli, Nicolas Larmonier, Elise Schmitt, Arnaud Parcellier, Dominique Cathelin, Carmen Garrido, Bruno Chauffert, Eric Solary, Bernard Bonnotte, François Martin

Research output: Contribution to journalArticlepeer-review

729 Scopus citations

Fingerprint Dive into the research topics of 'CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative'. Together they form a unique fingerprint.

Medicine & Life Sciences